TABLE 1.
Number of benign or malignant and melanocytic or non-melanocytic lesions included in the study. [Copyright: ©2013 Börve et al.]
| Histopathological diagnosis | Number of lesions (%) |
|---|---|
| Malignant melanocytic lesions | |
| Melanoma | 5 (7.2%) |
| Melanoma in situ | 7 (10.1%) |
| Benign melanocytic lesions | |
| Dysplastic nevus | 12 (17.4%) |
| Benign nevus | 6 (8.7%) |
| Malignant non-melanocytic lesions | |
| Basal cell carcinoma | 25 (36.2%) |
| Squamous cell carcinoma | 1 (1.4%) |
| Squamous cell carcinoma in situ | 1 (1.4%) |
| Cutaneous metastasis | 1 (1.4%) |
| Benign non-melanocytic lesions | |
| Seborrhoeic keratosis | 6 (8.7%) |
| Angioma | 2 (2.9%) |
| Other | 3 (4.3%) |
| Total | 69 (100%) |